Bortezomib-based induction therapy with high or low-dose dexamethasone in newly diagnosed, transplant-eligible multiple myeloma

Affiliations

¹ Department of Internal Medicine V, University Clinic Heidelberg, Heidelberg, Germany. elias.mai@med.uni-heidelberg.de.
² Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
³ Department of Internal Medicine V, University Clinic Heidelberg, Heidelberg, Germany.
⁴ Department of Hematology and Oncology, Asklepios Hospital Hamburg Altona, Hamburg, Germany.
⁵ Department of Internal Medicine III, University Medical Center Mainz, Mainz, Germany.
⁶ Department of Hematology and Oncology, Helios Hospital Berlin Buch, Berlin, Germany.
⁷ Department of Hematology, University Clinic Essen, Essen, Germany.
⁸ University Hospital Bonn, Bonn, Germany.
⁹ Department of Hematology and Oncology, Klinikum Baden Baden, Baden Baden, Germany.
¹⁰ Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany.
¹¹ Department of Medicine, Hematology/Oncology, Goethe-University of Frankfurt, Frankfurt, Germany.
¹² Department of Hematology and Oncology, Katholisches Krankenhaus Hagen, Hagen, Germany.
¹³ Medical Clinic, Charité University Medicine Berlin, Berlin, Germany.
¹⁴ Department of Internal Medicine I, University Hospital Köln, Köln, Germany.
¹⁵ Department of Hematology, Oncology and Immunology, University Hospital Tübingen, Tübingen, Germany.
¹⁶ Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg, Heidelberg, Germany.

Clinical Trial

Elias K Mai et al. Leukemia. 2019 Jan.

. 2019 Jan;33(1):258-261.

doi: 10.1038/s41375-018-0195-9. Epub 2018 Jun 29.

¹ Department of Internal Medicine V, University Clinic Heidelberg, Heidelberg, Germany. elias.mai@med.uni-heidelberg.de.
² Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
³ Department of Internal Medicine V, University Clinic Heidelberg, Heidelberg, Germany.
⁴ Department of Hematology and Oncology, Asklepios Hospital Hamburg Altona, Hamburg, Germany.
⁵ Department of Internal Medicine III, University Medical Center Mainz, Mainz, Germany.
⁶ Department of Hematology and Oncology, Helios Hospital Berlin Buch, Berlin, Germany.
⁷ Department of Hematology, University Clinic Essen, Essen, Germany.
⁸ University Hospital Bonn, Bonn, Germany.
⁹ Department of Hematology and Oncology, Klinikum Baden Baden, Baden Baden, Germany.
¹⁰ Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany.
¹¹ Department of Medicine, Hematology/Oncology, Goethe-University of Frankfurt, Frankfurt, Germany.
¹² Department of Hematology and Oncology, Katholisches Krankenhaus Hagen, Hagen, Germany.
¹³ Medical Clinic, Charité University Medicine Berlin, Berlin, Germany.
¹⁴ Department of Internal Medicine I, University Hospital Köln, Köln, Germany.
¹⁵ Department of Hematology, Oncology and Immunology, University Hospital Tübingen, Tübingen, Germany.
¹⁶ Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg, Heidelberg, Germany.

No abstract available

Publication types